BRPI1014760A2 - preparacao compreendendo insulina, nicotinamida e um aminoacido - Google Patents

preparacao compreendendo insulina, nicotinamida e um aminoacido

Info

Publication number: BRPI1014760A2
Authority: BR; Brazil
Prior art keywords: nicotinamide; insulin; preparation; amino acid; amino
Prior art date: 2009-06-26

Application number

BRPI1014760A

Other languages

English (en)

Inventor

Birk Olsen Helle

Naver Helle

Sturis Jeppe

Schlein Morten

Havelund Svend

Ludvigsen Svend

Ribel Ulla

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-06-26

Filing date

2010-06-25

Publication date

2017-07-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41351568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1014760(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-06-25 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2017-07-18 Publication of BRPI1014760A2 publication Critical patent/BRPI1014760A2/pt

2018-01-09 Publication of BRPI1014760A8 publication Critical patent/BRPI1014760A8/pt

2021-04-13 Publication of BRPI1014760B1 publication Critical patent/BRPI1014760B1/pt

2021-05-25 Publication of BRPI1014760B8 publication Critical patent/BRPI1014760B8/pt

Links

DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 title 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
150000001413 amino acids Chemical class 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
229960003966 nicotinamide Drugs 0.000 title 1
235000005152 nicotinamide Nutrition 0.000 title 1
239000011570 nicotinamide Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oil, Petroleum & Natural Gas (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

BRPI1014760A 2009-06-26 2010-06-25 preparação compreendendo insulina, nicotinamida e arginina BRPI1014760B8 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
EP09163940.1		2009-06-26
EP09163940		2009-06-26
US22216809P	2009-07-01	2009-07-01
US61/222,168		2009-07-01
PCT/EP2010/059069 WO2010149772A1 (en)	2009-06-26	2010-06-25	Preparation comprising insulin, nicotinamide and an amino acid

Publications (4)

Publication Number	Publication Date
BRPI1014760A2 true BRPI1014760A2 (pt)	2017-07-18
BRPI1014760A8 BRPI1014760A8 (pt)	2018-01-09
BRPI1014760B1 BRPI1014760B1 (pt)	2021-04-13
BRPI1014760B8 BRPI1014760B8 (pt)	2021-05-25

Family

ID=41351568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1014760A BRPI1014760B8 (pt)	2009-06-26	2010-06-25	preparação compreendendo insulina, nicotinamida e arginina

Country Status (20)

Country	Link
US (4)	US8324157B2 (pt)
EP (2)	EP2612677B1 (pt)
JP (2)	JP5669834B2 (pt)
KR (1)	KR101775000B1 (pt)
CN (2)	CN102470165B (pt)
AU (1)	AU2010264636B2 (pt)
BR (1)	BRPI1014760B8 (pt)
CA (1)	CA2764423A1 (pt)
DK (2)	DK2612677T3 (pt)
ES (2)	ES2543705T3 (pt)
HU (2)	HUE027239T2 (pt)
IL (1)	IL216520A (pt)
MX (1)	MX2011012764A (pt)
NO (1)	NO2017031I1 (pt)
PL (2)	PL2340033T3 (pt)
PT (2)	PT2612677E (pt)
RU (1)	RU2533217C3 (pt)
TW (1)	TWI459962B (pt)
WO (1)	WO2010149772A1 (pt)
ZA (1)	ZA201108942B (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9060927B2 (en)	2009-03-03	2015-06-23	Biodel Inc.	Insulin formulations for rapid uptake
US9018190B2 (en)	2009-03-27	2015-04-28	Adocia	Functionalized oligosaccharides
FR2943538B1 (fr)	2009-03-27	2011-05-20	Adocia	Formulation a action rapide d'insuline recombinante humaine
ES2543705T3 (es) *	2009-06-26	2015-08-21	Novo Nordisk A/S	Preparación que contiene insulina, nicotinamida y arginina
KR20140030125A (ko) *	2010-12-14	2014-03-11	노보 노르디스크 에이/에스	인슐린, 니코틴아미드 및 아미노산을 포함하는 제제
US9993529B2 (en)	2011-06-17	2018-06-12	Halozyme, Inc.	Stable formulations of a hyaluronan-degrading enzyme
GB201113880D0 (en) *	2011-08-12	2011-09-28	Archimed Llp	Novel compositions
US20130231281A1 (en)	2011-11-02	2013-09-05	Adocia	Rapid acting insulin formulation comprising an oligosaccharide
SG11201403714TA (en)	2011-12-30	2014-07-30	Halozyme Inc	Ph20 polypeptide variants, formulations and uses thereof
WO2013186138A1 (en) *	2012-06-14	2013-12-19	Novo Nordisk A/S	Preparation comprising insulin, nicotinamide and arginine
EP2919804B1 (fr)	2012-11-13	2018-01-31	Adocia	Formulation à action rapide d'insuline comprenant un composé anionique substitué
MX360420B (es)	2012-12-19	2018-10-31	Wockhardt Ltd	Una composicion acuosa estable que comprende insulina humana o un analogo o derivado de la misma.
TWI780236B (zh) *	2013-02-04	2022-10-11	法商賽諾菲公司	胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
PT2950780T (pt) *	2013-02-04	2020-07-07	Sanofi Sa	Formulações farmacêuticas estabilizadas de análogos de insulina e/ou derivados de insulina
TW201534726A (zh)	2013-07-03	2015-09-16	Halozyme Inc	熱穩定ｐｈ２０玻尿酸酶變異體及其用途
JP6641280B2 (ja)	2014-01-09	2020-02-05	サノフイＳａｎｏｆｉ	インスリンアナログおよび／またはインスリン誘導体の安定化された医薬製剤
WO2015120457A1 (en) *	2014-02-10	2015-08-13	Biodel Inc.	Stabilized ultra-rapid-acting insulin formulations
WO2015131902A1 (en) *	2014-03-07	2015-09-11	Jørgensen Klavs Holger	Novel fast acting insulin preparations
TWI685348B (zh) *	2014-05-08	2020-02-21	美國禮來大藥廠	速效胰島素組合物
FR3020947B1 (fr)	2014-05-14	2018-08-31	Adocia	Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en)	2014-05-14	2017-10-24	Adocia	Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
AR102869A1 (es)	2014-12-16	2017-03-29	Lilly Co Eli	Composiciones de insulina de rápida acción
US20180221385A1 (en)	2015-07-28	2018-08-09	Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et	A pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insulin
JO3749B1 (ar)	2015-08-27	2021-01-31	Lilly Co Eli	تركيبات إنسولين سريعة المفعول
FR3043557B1 (fr)	2015-11-16	2019-05-31	Adocia	Composition a action rapide d'insuline comprenant un citrate substitue
GB201607918D0 (en)	2016-05-06	2016-06-22	Arecor Ltd	Novel formulations
GB201613895D0 (en)	2016-08-12	2016-09-28	Arecor Ltd	Novel composition
EP4265296A3 (en)	2016-09-29	2023-12-20	Arecor Limited	Pharmaceutical formulation comprising an insulin compound
GB201707187D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
GB201707189D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
GB201707188D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
EP3773473B1 (en)	2018-04-04	2026-07-01	Arecor Limited	MEDICAL INFUSION PUMP SYSTEM FOR ADMINISTRATING AN INSULIN COMPOUND
EP3773474B1 (en)	2018-04-04	2026-01-07	Arecor Limited	Medical infusion pump system for the delivery of an insulin compound
JP7465813B2 (ja)	2018-04-04	2024-04-11	アレコルリミテッド	インスリン化合物の送達のための医療用注入ポンプシステム
FR3083984A1 (fr)	2018-07-23	2020-01-24	Adocia	Dispositif pour injecter une solution d'insuline(s)
FR3083985A1 (fr)	2018-07-23	2020-01-24	Adocia	Dispositif pour injecter une solution d'insuline(s)
WO2019243627A1 (fr)	2018-06-23	2019-12-26	Adocia	Dispositif pour injecter une solution d'insuline(s)
CN112739679B (zh)	2018-09-18	2024-03-12	伊莱利利公司	曲前列环素的特丁胺盐
GB202004814D0 (en)	2020-04-01	2020-05-13	Arecor Ltd	Novel formulations
AR131148A1 (es)	2022-11-26	2025-02-19	Obshchestvo S Ogranichennoy Otvetstvennostyu «Geropharm»	Composiciones de insulina de acción rápida (variantes de las mismas)
WO2024123214A1 (ru)	2022-12-04	2024-06-13	Общество С Ограниченной Ответственностью "Герофарм"	Композиция инсулина аспарта (варианты)
TW202521158A (zh) *	2023-11-17	2025-06-01	大陸商上海藥明生物技術有限公司	用於高濃度蛋白製劑的降黏穩定製劑

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4205126A (en) *	1978-01-01	1980-05-27	Cartaya Oscar A	Serum-free cell culture media
NZ199391A (en)	1981-01-02	1985-12-13	Genentech Inc	Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
ZA827928B (en) *	1981-10-30	1983-08-31	Novo Industri As	Stabilized insulin preparations and process for preparation thereof
DE3313386A1 (de) *	1983-04-13	1984-10-18	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München	Verfahren zur herstellung von nicht-brennbaren, thermisch isolierenden formkoerpern aus geblaehtem perlit
DK58285D0 (da)	1984-05-30	1985-02-08	Novo Industri As	Peptider samt fremstilling og anvendelse deraf
DK336188D0 (da)	1988-06-20	1988-06-20	Nordisk Gentofte	Propeptider
DK105489D0 (da)	1989-03-03	1989-03-03	Novo Nordisk As	Polypeptid
US5382574A (en)	1989-12-21	1995-01-17	Novo Nordisk A/S	Insulin preparations containing nicotinic acid or nicotinamide
WO1995016708A1 (en)	1993-12-17	1995-06-22	Novo Nordisk A/S	Proinsulin-like compounds
RU2175556C2 (ru) *	1994-03-07	2001-11-10	Инхейл Терапьютик Системз	Способы и композиции для легочной доставки инсулина
US6500645B1 (en)	1994-06-17	2002-12-31	Novo Nordisk A/S	N-terminally extended proteins expressed in yeast
ZA954983B (en)	1994-06-17	1996-02-14	Novo Nordisk As	N-terminally extended proteins expressed in yeast
WO1996010417A1 (en) *	1994-10-04	1996-04-11	Novo Nordisk A/S	PREPARATIONS CONTAINING AspB28 HUMAN INSULIN AND NICOTINAMIDE
KR0150565B1 (ko)	1995-02-15	1998-08-17	김정재	유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
IL118127A0 (en)	1995-05-05	1996-09-12	Lilly Co Eli	Single chain insulin with high bioactivity
US6043092A (en) *	1996-03-18	2000-03-28	University Of Pittsburgh	Cell culture media for mammalian cells
US5866538A (en)	1996-06-20	1999-02-02	Novo Nordisk A/S	Insulin preparations containing NaCl
AR012894A1 (es) *	1997-06-13	2000-11-22	Lilly Co Eli	Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma.
DK1283051T3 (da) *	1997-06-13	2006-10-16	Lilly Co Eli	Stabile insulinformuleringer
US6734162B2 (en) *	2000-01-24	2004-05-11	Minimed Inc.	Mixed buffer system for stabilizing polypeptide formulations
US6573237B2 (en)	2001-03-16	2003-06-03	Eli Lilly And Company	Protein formulations
DE10114178A1 (de) *	2001-03-23	2002-10-10	Aventis Pharma Gmbh	Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
WO2003020201A2 (en) *	2001-08-28	2003-03-13	Eli Lilly And Company	Pre-mixes of glp-1 and basal insulin
US7115563B2 (en)	2002-05-29	2006-10-03	Insignion Holding Limited	Composition and its therapeutic use
US20050232974A1 (en)	2004-04-19	2005-10-20	Gore Makarand P	System and a method for pharmaceutical dosage preparation using jettable microemulsions
WO2007121256A2 (en)	2006-04-12	2007-10-25	Biodel, Inc.	Rapid acting and long acting insulin combination formulations
CN101541830A (zh)	2006-09-22	2009-09-23	诺沃-诺迪斯克有限公司	蛋白酶抗性的胰岛素类似物
WO2008037735A1 (en)	2006-09-27	2008-04-03	Novo Nordisk A/S	Method for making maturated insulin polypeptides
CA2673054C (en)	2006-12-15	2016-05-10	Tima Foundation	Novel compositions and uses thereof
US8575096B2 (en) *	2007-08-13	2013-11-05	Novo Nordisk A/S	Rapid acting insulin analogues
ES2543705T3 (es) *	2009-06-26	2015-08-21	Novo Nordisk A/S	Preparación que contiene insulina, nicotinamida y arginina

2010
- 2010-06-25 ES ES13158960.8T patent/ES2543705T3/es active Active
- 2010-06-25 CA CA2764423A patent/CA2764423A1/en not_active Withdrawn
- 2010-06-25 RU RU2012100397A patent/RU2533217C3/ru active Protection Beyond IP Right Term
- 2010-06-25 PL PL10730134T patent/PL2340033T3/pl unknown
- 2010-06-25 EP EP20130158960 patent/EP2612677B1/en active Active
- 2010-06-25 JP JP2012516763A patent/JP5669834B2/ja active Active
- 2010-06-25 DK DK13158960.8T patent/DK2612677T3/en active
- 2010-06-25 BR BRPI1014760A patent/BRPI1014760B8/pt active IP Right Grant
- 2010-06-25 DK DK10730134.3T patent/DK2340033T3/da active
- 2010-06-25 MX MX2011012764A patent/MX2011012764A/es active IP Right Grant
- 2010-06-25 ES ES10730134.3T patent/ES2440289T3/es active Active
- 2010-06-25 PT PT131589608T patent/PT2612677E/pt unknown
- 2010-06-25 PT PT107301343T patent/PT2340033E/pt unknown
- 2010-06-25 KR KR1020127000115A patent/KR101775000B1/ko active Active
- 2010-06-25 EP EP10730134.3A patent/EP2340033B1/en active Active
- 2010-06-25 CN CN201080029548.9A patent/CN102470165B/zh active Active
- 2010-06-25 AU AU2010264636A patent/AU2010264636B2/en active Active
- 2010-06-25 HU HUE13158960A patent/HUE027239T2/en unknown
- 2010-06-25 PL PL13158960T patent/PL2612677T3/pl unknown
- 2010-06-25 CN CN201410659076.5A patent/CN104667264B/zh active Active
- 2010-06-25 WO PCT/EP2010/059069 patent/WO2010149772A1/en not_active Ceased
- 2010-06-28 TW TW099121012A patent/TWI459962B/zh active
2011
- 2011-11-22 IL IL216520A patent/IL216520A/en active IP Right Grant
- 2011-12-01 US US13/309,134 patent/US8324157B2/en active Active
- 2011-12-06 ZA ZA2011/08942A patent/ZA201108942B/en unknown
2012
- 2012-11-07 US US13/671,034 patent/US20130281364A1/en not_active Abandoned
2014
- 2014-03-24 US US14/223,408 patent/US20140206610A1/en not_active Abandoned
- 2014-11-04 JP JP2014223915A patent/JP6026485B2/ja active Active
2015
- 2015-03-16 US US14/658,358 patent/US20150182595A1/en not_active Abandoned
2017
- 2017-06-06 HU HUS1700027C patent/HUS1700027I1/hu unknown
- 2017-07-06 NO NO2017031C patent/NO2017031I1/no unknown

Also Published As

Publication number	Publication date
JP6026485B2 (ja)	2016-11-16
ZA201108942B (en)	2012-08-29
US20130281364A1 (en)	2013-10-24
WO2010149772A1 (en)	2010-12-29
DK2340033T3 (da)	2014-01-20
PT2340033E (pt)	2014-02-04
AU2010264636B2 (en)	2013-06-27
TW201100093A (en)	2011-01-01
IL216520A0 (en)	2012-02-29
ES2440289T3 (es)	2014-01-28
CN102470165A (zh)	2012-05-23
PL2340033T3 (pl)	2014-03-31
JP2015071608A (ja)	2015-04-16
IL216520A (en)	2017-08-31
EP2612677A1 (en)	2013-07-10
KR101775000B1 (ko)	2017-09-04
TWI459962B (zh)	2014-11-11
PT2612677E (pt)	2015-09-10
CN102470165B (zh)	2014-12-24
BRPI1014760B8 (pt)	2021-05-25
MX2011012764A (es)	2012-01-20
NO2017031I1 (no)	2017-07-06
US20150182595A1 (en)	2015-07-02
US20120135920A1 (en)	2012-05-31
EP2340033B1 (en)	2013-10-09
BRPI1014760B1 (pt)	2021-04-13
JP2012530768A (ja)	2012-12-06
RU2012100397A (ru)	2013-08-10
DK2612677T3 (en)	2015-07-27
CN104667264B (zh)	2018-09-07
RU2533217C2 (ru)	2014-11-20
PL2612677T3 (pl)	2015-10-30
US20140206610A1 (en)	2014-07-24
EP2612677B1 (en)	2015-05-06
HUS1700027I1 (hu)	2017-07-28
CN104667264A (zh)	2015-06-03
KR20120047226A (ko)	2012-05-11
RU2533217C3 (ru)	2020-12-21
ES2543705T3 (es)	2015-08-21
CA2764423A1 (en)	2010-12-29
HUE027239T2 (en)	2016-10-28
AU2010264636A1 (en)	2012-01-12
JP5669834B2 (ja)	2015-02-18
US8324157B2 (en)	2012-12-04
BRPI1014760A8 (pt)	2018-01-09
EP2340033A1 (en)	2011-07-06

Legal Events

Date	Code	Title	Description
2018-01-23	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-10	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-05-21	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-06-25	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2020-11-24	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-03-02	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-04-13	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/06/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/06/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

Publication	Publication Date	Title
BRPI1014760A8 (pt)	2018-01-09	preparação compreendendo insulina, nicotinamida e um aminoácido
NO2024044I1 (no)	2024-10-08	Insulin icodec
IL280949A (en)	2021-04-29	Ph20 polypeptide variants, formulations and uses thereof
BR112013014856A2 (pt)	2016-10-18	preparação compreendendo insulina, nicotinamida e um aminoácido
IL244941A (en)	2017-12-31	Insulin preparations containing methionine
IL243932A0 (en)	2016-04-21	Certain chemical entities, compositions and methods
IL222930B (en)	2019-01-31	Chlorotoxin variants, conjugates and methods for their use
PL2403520T3 (pl)	2018-10-31	Preparaty insuliny do szybkiego wychwytu
BR112013010725A2 (pt)	2016-07-05	método, e, composição
HUE037163T2 (hu)	2018-08-28	Hemoglobin készítmények
ZA201008450B (en)	2011-07-27	Sweetener,methods of preparing sweetener and applications thereof
DK3590949T3 (da)	2022-07-11	Ribonukleinsyrer indeholdende n1-methyl-pseudouracil og anvendelse heraf
HUE062860T2 (hu)	2023-12-28	Magas koncentrációjú gyógyszerészeti készítmények
BR112013013584A2 (pt)	2016-09-06	endoscópio, e, método
DK3196309T3 (da)	2019-11-25	Thraustochytrider, fedtsyresammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
BR112012029028A2 (pt)	2016-08-02	laringoscópio, braços de laringoscópio e métodos de fabricação
FI20096339L (fi)	2011-06-17	Liima-aine, menetelmä sen valmistamiseksi sekä sen käyttö
IL231444A0 (en)	2014-04-30	Aniline derivativs, their preparation and their therapeutic application
EP2415869A4 (en)	2013-06-19	MODIFIED OLIGO-NUCLEIC ACID MOLECULE, PROCESS FOR PREPARATION AND USES THEREOF
EP2475430A4 (en)	2013-05-15	GRANULATED ANTHELMINTIC PREPARATIONS AND OUTPUT SYSTEMS THEREFOR
IL207202A0 (en)	2010-12-30	Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals
IL224367B (en)	2020-05-31	Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
GB2488494B (en)	2014-12-31	Solution, use and method of preparation thereof
IL207204A0 (en)	2010-12-30	Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
HRP20150021T1 (xx)	2015-03-27	Spojevi fenantrenona, pripravci i postupci